(Q38068387)

28 August 2017

1 reference

title

Ras/MAPK syndromes and childhood hemato-oncological diseases (English)

1 reference

28 August 2017

Yoko Aoki

1

1 reference

28 August 2017

Yoichi Matsubara

series ordinal

2

1 reference

28 August 2017

publication date

19 December 2012

1 reference

International Journal of Hematology

28 August 2017

published in

1 reference

28 August 2017

volume

97

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

30-36

1 reference

https://scigraph.springernature.com/pub.10.1007/s12185-012-1239-y

28 August 2017

exact match

0 references

cites work

Noonan syndrome: clinical features, diagnosis, and management guidelines

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Noonan syndrome: the changing phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Five additional Costello syndrome patients with rhabdomyosarcoma: proposal for a tumor screening protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

New multiple congenital anomalies/mental retardation syndrome with cardio-facio-cutaneous involvement--the CFC syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Cardio-facio-cutaneous syndrome: does genotype predict phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Mapping a gene for Noonan syndrome to the long arm of chromosome 12

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Germline mutations in HRAS proto-oncogene cause Costello syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

A restricted spectrum of NRAS mutations causes Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Germline gain-of-function mutations in RAF1 cause Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Germline gain-of-function mutations in SOS1 cause Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Germline KRAS mutations cause Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Germ-line and somatic PTPN11 mutations in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Molecular and clinical analysis of RAF1 in Noonan syndrome and related disorders: dephosphorylation of serine 259 as the essential mechanism for mutant activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype-phenotype correlation in Korean patients with Noonan syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Guilty as charged: B-RAF is a human oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: transmission through four generations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

soc-2 encodes a leucine-rich repeat protein implicated in fibroblast growth factor receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Mutation analysis of the SHOC2 gene in Noonan-like syndrome and in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Noonan syndrome gain-of-function mutations in NRAS cause zebrafish gastrulation defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Non-hodgkin lymphoma in a patient with cardiofaciocutaneous syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Recurrent BRAF mutations in Langerhans cell histiocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12185-012-1239-Y

Clinical and molecular studies in a large Dutch family with Noonan syndrome

21 January 2018

1 reference

12 December 2020

A new syndrome: mental subnormality and nasal papillomata

1 reference

12 December 2020

Prevalence and clinical features of Costello syndrome and cardio-facio-cutaneous syndrome in Japan: findings from a nationwide epidemiological survey

1 reference

12 December 2020

Costello syndrome with severe cutis laxa and mosaic HRAS G12S mutation

1 reference

12 December 2020

NRAS Mutations in Noonan Syndrome.

1 reference

12 December 2020

Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations.

1 reference

12 December 2020

Small GTP-binding proteins

1 reference

12 December 2020

A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive condition

1 reference

12 December 2020

10.1007/S12185-012-1239-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1035367408

0 references

1 reference